Sihuan Pharmaceutical Holdings Group Ltd - ESG Rating & Company Profile powered by AI
If you work at Sihuan Pharmaceutical Holdings Group Ltd and you wish to licence your ESG rating, please get in touch. This report of Sihuan Pharmaceutical Holdings Group Ltd employs information from across the web as well as from public filings by Sihuan Pharmaceutical Holdings Group Ltd. Alternative companies in the scoring industry group for Sihuan Pharmaceutical Holdings Group Ltd are shownin the table.
Sihuan Pharmaceutical Holdings Group Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.6; made up of an environmental score of 6.7, social score of 8.0 and governance score of 8.0.
7.6
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
140 | Sun Pharmaceutical Industries Ltd | 7.7 | High |
140 | Teva Pharmaceutical Industries Ltd | 7.7 | High |
149 | Sihuan Pharmaceutical Holdings Group Ltd | 7.6 | High |
149 | Alexion Pharmaceuticals Inc | 7.6 | High |
149 | Hisamitsu Pharmaceutical Co Inc | 7.6 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sihuan Pharmaceutical Holdings Group Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose current and historical energy intensity?
Does Sihuan Pharmaceutical Holdings Group Ltd report the average age of the workforce?
Does Sihuan Pharmaceutical Holdings Group Ltd reference operational or capital allocation in relation to climate change?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose its ethnicity pay gap?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose cybersecurity risks?
Does Sihuan Pharmaceutical Holdings Group Ltd offer flexible work?
Does Sihuan Pharmaceutical Holdings Group Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose the number of employees in R&D functions?
Does Sihuan Pharmaceutical Holdings Group Ltd conduct supply chain audits?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sihuan Pharmaceutical Holdings Group Ltd conduct 360 degree staff reviews?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose the individual responsible for D&I?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose current and / or historical scope 2 emissions?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose water use targets?
Does Sihuan Pharmaceutical Holdings Group Ltd have careers partnerships with academic institutions?
Did Sihuan Pharmaceutical Holdings Group Ltd have a product recall in the last two years?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose incidents of discrimination?
Does Sihuan Pharmaceutical Holdings Group Ltd allow for Work Councils/Collective Agreements to be formed?
Has Sihuan Pharmaceutical Holdings Group Ltd issued a profit warning in the past 24 months?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose parental leave metrics?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose climate scenario or pathway analysis?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose the pay ratio of women to men?
Does Sihuan Pharmaceutical Holdings Group Ltd support suppliers with sustainability related research and development?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sihuan Pharmaceutical Holdings Group Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sihuan Pharmaceutical Holdings Group Ltd involved in embryonic stem cell research?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose GHG and Air Emissions intensity?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose its waste policy?
Does Sihuan Pharmaceutical Holdings Group Ltd report according to TCFD requirements?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose energy use targets?
Does Sihuan Pharmaceutical Holdings Group Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sihuan Pharmaceutical Holdings Group Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Sihuan Pharmaceutical Holdings Group Ltd
These potential risks are based on the size, segment and geographies of the company.
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.